GYRE THERAPEUTICS INC COM - Stock (CBIO)

CUSIP: 14888D208

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / Stock
Total 13F shares
1,179,880
Share change
+996,412
Total reported value
$5,484,000
Price per share
$4.65
Number of holders
16
Value change
+$4,495,339
Number of buys
14
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 14888D208?
CUSIP 14888D208 identifies CBIO - GYRE THERAPEUTICS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GYRE THERAPEUTICS INC COM - Stock (CBIO) as of Q2 2017

As of 30 Jun 2017, GYRE THERAPEUTICS INC COM - Stock (CBIO) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,179,880 shares. The largest 10 holders included Sio Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, NEA Management Company, LLC, ZACKS INVESTMENT MANAGEMENT, UBS Group AG, Bank of New York Mellon Corp, and Virtu KCG Holdings LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.